These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 28237749)

  • 41. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
    Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
    Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
    Zhao D; Zhang H; Yang S; He W; Luan Y
    Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
    Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
    Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.
    Zhang J; Han J; Zhang X; Jiang J; Xu M; Zhang D; Han J
    Carbohydr Polym; 2015 Sep; 129():25-34. PubMed ID: 26050884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo evaluation of redox-responsive sorafenib carrier nanomicelles synthesized from poly (acryic acid) -cystamine hydrochloride-D-α-tocopherol succinate.
    Liu Y; Yang J; Wang X; Liu J; Wang Z; Liu H; Chen L
    J Biomater Sci Polym Ed; 2016 Dec; 27(17):1729-1747. PubMed ID: 27632696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
    Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
    Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coloaded Nanoparticles of Paclitaxel and Piperlongumine for Enhancing Synergistic Antitumor Activities and Reducing Toxicity.
    Liu Q; Zhao D; Zhu X; Chen H; Yang Y; Xu J; Zhang Q; Fan A; Li N; Guo C; Kong Y; Lu Y; Chen X
    J Pharm Sci; 2017 Oct; 106(10):3066-3075. PubMed ID: 28552690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery.
    Wang F; Li J; Tang X; Huang K; Chen L
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110925. PubMed ID: 32155455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma:
    Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R
    Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
    Liang N; Sun S; Li X; Piao H; Piao H; Cui F; Fang L
    Int J Pharm; 2012 Feb; 423(2):480-8. PubMed ID: 22183133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
    Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
    Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
    J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
    Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.